Middle Aged

Sansbury, L. B., Rothnie, K. J., Bains, C., Compton, C., Anley, G., & Ismaila, A. S. (2021). Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. Int J Chron Obstruct Pulmon Dis, 16, 2591-2604. http://doi.org/10.2147/copd.s318969
Suissa, S., Dell'Aniello, S., & Ernst, P. (2022). Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. Copd, 19, 133-141. http://doi.org/10.1080/15412555.2022.2045265
Suissa, S., Dell'Aniello, S., & Ernst, P. (2022). Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety. Copd, 19, 109-117. http://doi.org/10.1080/15412555.2022.2035705
Stafford, M., Knight, H., Hughes, J., Alarilla, A., Mondor, L., Kone, P., et al. (2022). Associations between multiple long-term conditions and mortality in diverse ethnic groups. Plos One, 17, e0266418. http://doi.org/10.1371/journal.pone.0266418
Li, X., Raventós, B., Roel, E., Pistillo, A., Martinez-Hernandez, E., Delmestri, A., et al. (2022). Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. Bmj, 376, e068373. http://doi.org/10.1136/bmj-2021-068373
Lee, S. I., Azcoaga-Lorenzo, A., Agrawal, U., Kennedy, J. I., Fagbamigbe, A. F., Hope, H., et al. (2022). Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study. Bmc Pregnancy Childbirth, 22, 120. http://doi.org/10.1186/s12884-022-04442-3
Strongman, H., Carreira, H., De Stavola, B. L., Bhaskaran, K., & Leon, D. A. (2022). Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink. Plos Med, 19, e1003870. http://doi.org/10.1371/journal.pmed.1003870